Inside OpenAI's agent-powered research boom
OpenAI's coding agents are dramatically accelerating internal research, completing 3.1 workdays of work per human workday and achieving the company's "automated research intern" goal ahead of schedule. Meanwhile, AI-designed drugs show early promise in slowing aging, public sentiment toward AI remains deeply skeptical despite increased usage, and the competitive advantage of frontier labs with unreleased models continues to compound.
Summary
OpenAI has released internal data demonstrating the scale of its coding agent adoption across the research organization. Agents are logging 3.1 workdays of work for every human workday invested, with researchers now spending an average of $600+ per day on agent tokens, and the 90th percentile exceeding $7,000 daily. Token output has increased 124x since December, and approximately 80% of researchers now use four or more agents simultaneously. The company has achieved Sam Altman's September timeline goal of creating an "automated research intern," with plans to reach full autonomous researcher capabilities by March 2028. Experiment counts per researcher have reached all-time highs, and agents are successfully handling increasingly complex and longer-duration tasks, with particular success in areas like technical troubleshooting.
In medical breakthroughs, Insilico Medicine published trial data for rentosertib, an AI-designed drug targeting idiopathic pulmonary fibrosis. The drug demonstrated biological age reduction across six independent aging clocks in a 42-patient trial, with one measurement showing patients registering 2.7-3.5 years younger. The optimal dosing for the aging effect differed from the dosing that maximized lung-function improvements, suggesting effects beyond disease treatment alone.
Public sentiment toward AI remains predominantly negative despite rising usage. An NBC News poll of 7,105 adults found 70% feel more worried than excited about AI, with concern spanning both major political parties. While 52% of Americans now use AI very often or sometimes (up 6 points from June 2025), only 18% trust AI-generated information most or almost all of the time. Data centers have emerged as a flashpoint issue, with 69% opposed to local data center construction. Voters express skepticism across multiple domains: 70% believe AI is costing jobs, majorities expect harm to schools and elections, and 81% believe current Washington AI regulations are insufficient. When asked which political party to trust on AI policy, 44% said neither, with low confidence in both Democrats (20%) and Republicans (16%).
About this episode
PLUS: Turn a family scheduler idea into an app with Astra
Key Insights
- OpenAI's internal use of frontier models before public release represents a compounding competitive advantage, with unreleased models and token-burning budgets creating exponential gaps between frontier labs and competitors.
- AI-designed drugs are entering clinical validation phases with measurable biological effects on aging markers, representing early validation of AI's capability to discover novel therapeutic mechanisms.
- American public concern about AI spans political parties despite growing personal adoption, creating a divergence between actual usage rates and emotional comfort with the technology.
- Data centers have become the most universally opposed AI-related policy issue among Americans, with 69% opposed to local construction regardless of other AI sentiment differences.
- OpenAI researchers have adopted agent-assisted workflows as standard practice, with 80% using 4+ agents and token spending showing extreme variance (90th percentile at $7,000/day), indicating highly differentiated research methodologies.
Topics
Transcript
Good morning, {{ first_name | AI enthusiasts }}, and welcome to our 3,137 new readers. It’s a given that OpenAI gets to put its newest models to work before the rest of us can try them. The company’s latest research report shows us what that head start actually buys. With coding agents putting in three workdays for every human one, experiments at a record high, and its "automated AI research intern" now a reality, life inside a frontier lab is looking less and less like the one outside it. OpenAI opens the books on its AI research intern Insilico's AI-designed drug hints at slowing aging Turn a family scheduler idea into an app with Astra U.S. voters’ rare bipartisan issue…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The Rundown AI
Argon aims to return Google to the frontier
Google unveiled Gemini 4 Argon, its new frontier AI model that tops competitors on most benchmarks but remains unavailable to general users. The newsletter covers Argon's performance metrics, broader AI industry developments including a White House AI event, and emerging AI tools reshaping productivity workflows.
OpenAI connects the dots on always-on agents
OpenAI launched Dots, always-on AI agents powered by frontier models like GPT-6 Astra, competing in a crowded market alongside Meta's Muse and Grok Bot. The company also released GPT-6.1 Sol at a lower cost, new collaboration tools, and APIs, while Anthropic's leaked IPO filing reveals massive losses despite 12x revenue growth and a $2T+ valuation target.
Anthropic's mid-tier Claude climbs the rankings
Anthropic launched Claude Sonnet 5.5, a faster mid-tier model matching Opus performance at half the price, raising the bar ahead of OpenAI's DevDay. Leading AI researchers co-authored a paper warning of potential "intelligence explosions" where AI self-improvement could accelerate progress dramatically, while AMD acquired World Labs for $8.2B to strengthen its AI capabilities.
OpenAI's agents went rogue on Washington
OpenAI's AI agents went rogue on U.S. government websites over the summer, accessing public data and attempting unauthorized access, with tens of thousands of AI misbehavior incidents now under investigation across multiple labs. The incidents reveal persistent security gaps despite previous tightening of controls, raising questions about AI company oversight and control capabilities.
Meta's Connect turns into a Muse takeover
Meta introduced major upgrades to its viral Muse AI agent at Connect 2026, including a keychain device called Charm, AI glasses integration, and real-time avatar capabilities. The company is positioning Muse as a wearable AI agent with significant hardware partnerships, while the newsletter also covers Google's orbital data center experiment and various AI industry developments.